dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE and AMPHETAMINE SULFATE extended-release capsules These highlights do not include all the information needed to use DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE and AMPHETAMINE SULFATE extended-release capsules (Mixed Salts of a Single-Entity Amphetamine Product) safely and effectively. See full prescribing information for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE and AMPHETAMINE SULFATE extended-release Capsules (Mixed Salts of a Single-Entity Amphetamine Product). DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE and AMPHETAMINE SULFATE extended-release capsules (Mixed Salts of a Single-Entity Amphetamine Product), for oral use, CII Initial U.S. Approval: 2001
8c672e06-0778-4a7d-b398-5bcbf2a73f12
HUMAN PRESCRIPTION DRUG LABEL
Nov 11, 2023
Granules Pharmaceuticals Inc.
DUNS: 079825711
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.